Cargando…

Tracing cancer evolution and heterogeneity using Hi-C

Chromosomal rearrangements can initiate and drive cancer progression, yet it has been challenging to evaluate their impact, especially in genetically heterogeneous solid cancers. To address this problem we developed HiDENSEC, a new computational framework for analyzing chromatin conformation capture...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdmann-Pham, Dan Daniel, Batra, Sanjit Singh, Turkalo, Timothy K., Durbin, James, Blanchette, Marco, Yeh, Iwei, Shain, Hunter, Bastian, Boris C., Song, Yun S., Rokhsar, Daniel S., Hockemeyer, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628133/
https://www.ncbi.nlm.nih.gov/pubmed/37932252
http://dx.doi.org/10.1038/s41467-023-42651-2
_version_ 1785131688743927808
author Erdmann-Pham, Dan Daniel
Batra, Sanjit Singh
Turkalo, Timothy K.
Durbin, James
Blanchette, Marco
Yeh, Iwei
Shain, Hunter
Bastian, Boris C.
Song, Yun S.
Rokhsar, Daniel S.
Hockemeyer, Dirk
author_facet Erdmann-Pham, Dan Daniel
Batra, Sanjit Singh
Turkalo, Timothy K.
Durbin, James
Blanchette, Marco
Yeh, Iwei
Shain, Hunter
Bastian, Boris C.
Song, Yun S.
Rokhsar, Daniel S.
Hockemeyer, Dirk
author_sort Erdmann-Pham, Dan Daniel
collection PubMed
description Chromosomal rearrangements can initiate and drive cancer progression, yet it has been challenging to evaluate their impact, especially in genetically heterogeneous solid cancers. To address this problem we developed HiDENSEC, a new computational framework for analyzing chromatin conformation capture in heterogeneous samples that can infer somatic copy number alterations, characterize large-scale chromosomal rearrangements, and estimate cancer cell fractions. After validating HiDENSEC with in silico and in vitro controls, we used it to characterize chromosome-scale evolution during melanoma progression in formalin-fixed tumor samples from three patients. The resulting comprehensive annotation of the genomic events includes copy number neutral translocations that disrupt tumor suppressor genes such as NF1, whole chromosome arm exchanges that result in loss of CDKN2A, and whole-arm copy-number neutral loss of homozygosity involving PTEN. These findings show that large-scale chromosomal rearrangements occur throughout cancer evolution and that characterizing these events yields insights into drivers of melanoma progression.
format Online
Article
Text
id pubmed-10628133
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106281332023-11-08 Tracing cancer evolution and heterogeneity using Hi-C Erdmann-Pham, Dan Daniel Batra, Sanjit Singh Turkalo, Timothy K. Durbin, James Blanchette, Marco Yeh, Iwei Shain, Hunter Bastian, Boris C. Song, Yun S. Rokhsar, Daniel S. Hockemeyer, Dirk Nat Commun Article Chromosomal rearrangements can initiate and drive cancer progression, yet it has been challenging to evaluate their impact, especially in genetically heterogeneous solid cancers. To address this problem we developed HiDENSEC, a new computational framework for analyzing chromatin conformation capture in heterogeneous samples that can infer somatic copy number alterations, characterize large-scale chromosomal rearrangements, and estimate cancer cell fractions. After validating HiDENSEC with in silico and in vitro controls, we used it to characterize chromosome-scale evolution during melanoma progression in formalin-fixed tumor samples from three patients. The resulting comprehensive annotation of the genomic events includes copy number neutral translocations that disrupt tumor suppressor genes such as NF1, whole chromosome arm exchanges that result in loss of CDKN2A, and whole-arm copy-number neutral loss of homozygosity involving PTEN. These findings show that large-scale chromosomal rearrangements occur throughout cancer evolution and that characterizing these events yields insights into drivers of melanoma progression. Nature Publishing Group UK 2023-11-06 /pmc/articles/PMC10628133/ /pubmed/37932252 http://dx.doi.org/10.1038/s41467-023-42651-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Erdmann-Pham, Dan Daniel
Batra, Sanjit Singh
Turkalo, Timothy K.
Durbin, James
Blanchette, Marco
Yeh, Iwei
Shain, Hunter
Bastian, Boris C.
Song, Yun S.
Rokhsar, Daniel S.
Hockemeyer, Dirk
Tracing cancer evolution and heterogeneity using Hi-C
title Tracing cancer evolution and heterogeneity using Hi-C
title_full Tracing cancer evolution and heterogeneity using Hi-C
title_fullStr Tracing cancer evolution and heterogeneity using Hi-C
title_full_unstemmed Tracing cancer evolution and heterogeneity using Hi-C
title_short Tracing cancer evolution and heterogeneity using Hi-C
title_sort tracing cancer evolution and heterogeneity using hi-c
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628133/
https://www.ncbi.nlm.nih.gov/pubmed/37932252
http://dx.doi.org/10.1038/s41467-023-42651-2
work_keys_str_mv AT erdmannphamdandaniel tracingcancerevolutionandheterogeneityusinghic
AT batrasanjitsingh tracingcancerevolutionandheterogeneityusinghic
AT turkalotimothyk tracingcancerevolutionandheterogeneityusinghic
AT durbinjames tracingcancerevolutionandheterogeneityusinghic
AT blanchettemarco tracingcancerevolutionandheterogeneityusinghic
AT yehiwei tracingcancerevolutionandheterogeneityusinghic
AT shainhunter tracingcancerevolutionandheterogeneityusinghic
AT bastianborisc tracingcancerevolutionandheterogeneityusinghic
AT songyuns tracingcancerevolutionandheterogeneityusinghic
AT rokhsardaniels tracingcancerevolutionandheterogeneityusinghic
AT hockemeyerdirk tracingcancerevolutionandheterogeneityusinghic